SEC Contract Filing

Filing Date: 2022-08-09

Document Content:
<DOCUMENT>
<TYPE>EX-10.1
<SEQUENCE>2
<FILENAME>tm2222833d1_ex10-1.htm
<DESCRIPTION>EXHIBIT 10.1
<TEXT>
<HTML>
<HEAD>
 <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="text-align: right; margin: 0"><B>Exhibit&nbsp;10.1</B></P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B>CERTAIN INFORMATION CONTAINED IN THIS EXHIBIT,
MARKED BY [***], HAS BEEN EXCLUDED FROM THIS EXHIBIT&nbsp;BECAUSE THE REGISTRANT HAS DETERMINED THAT IT IS BOTH NOT MATERIAL AND IS THE
TYPE THAT THE REGISTRANT TREATS AS PRIVATE OR CONFIDENTIAL.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>SECURITIES PURCHASE AGREEMENT</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">This Securities Purchase Agreement,
dated as of August&nbsp;8, 2022 (the &#8220;<B>Agreement</B>&#8221;), is by and between Enalare Therapeutics Inc., a Delaware corporation
with its principal offices at 161 Hodge Road, Princeton, NJ 08540 (the &#8220;<B>Company</B>&#8221;), and Eagle Pharmaceuticals,&nbsp;Inc.,
a Delaware corporation with its principal offices at 50 Tice Boulevard, Suite&nbsp;315, Woodcliff Lake, NJ 07677 (the &#8220;<B>Purchaser</B>&#8221;).
Each the Company and Purchaser are a &#8220;<B>Party</B>&#8221; and collectively referred to herein as the &#8220;<B>Parties</B>.&#8221;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">WHEREAS, the Company desires
to issue and sell to the Purchaser a number of shares (each a &#8220;<B>Share</B>&#8221; and collectively, as applicable, the &#8220;<B>Shares</B>&#8221;)
of the common stock, par value $0.0001 per share (the &#8220;<B>Common Stock</B>&#8221;) of the Company and the Purchaser desires to purchase
and acquire the Shares, all on the terms and subject to the conditions as set forth in this Agreement;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">WHEREAS, the Purchaser desires
to provide further payments and to purchase additional Shares, and the Company desires to issue and sell such Shares, upon the occurrence
of certain milestone events as described herein;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">WHEREAS,
the Company and the </FONT>Purchaser are executing and delivering this Agreement in reliance upon the exemption from securities registration
afforded by Section&nbsp;4(a)(2)&nbsp;of the Securities Act of 1933, as amended (the &#8220;<B>Securities Act</B>&#8221;), and Rule&nbsp;506
of Regulation D (&#8220;<B>Regulation D</B>&#8221;) as promulgated by the U.S. Securities and Exchange Commission (the &#8220;<B>SEC</B>&#8221;)
under the Securities Act;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">WHEREAS,
simultaneously with the entry into this Agreement, the Company, the Purchaser and all of the Securityholders have entered into a Security
Purchase Option Agreement attached hereto as <FONT STYLE="font-variant: small-caps"><B>Exhibit&nbsp;A</B></FONT> (the &#8220;<B>Security
Purchase Option Agreement</B>&#8221;), </FONT>pursuant to which the Securityholders are granting the Purchaser the option to purchase
all of the Company capital stock held by such Securityholders on the terms set forth therein, following the execution of such option the
Purchaser would hold 100% of the outstanding capital stock of the Company;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">WHEREAS,
it is a condition to the consummation of the transactions contemplated by this Agreement for the parties to amend and restate the Stockholders&#8217;
Agreement in the form attached hereto as <FONT STYLE="font-variant: small-caps"><B>Exhibit&nbsp;B </B></FONT>(the &#8220;<B>A&amp;R Stockholders
Agreement</B>&#8221;), </FONT>pursuant to which the Company will agree to provide certain rights to the Purchaser in respect of the Purchaser&#8217;s
ownership of the Shares following the entry into this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 1; Options: NewSection -->
 <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"> </P></DIV>
 <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
 <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">NOW THEREFORE, in consideration
of the mutual agreements, representations, warranties and covenants herein contained, the Parties hereto agree as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0